Observing Radiotherapy With Simultaneous Boost for Head and Neck Cancer Patients
Observes outcomes of radiotherapy with simultaneous boost in adults with head and neck cancer.
Plain-language title generated from the registry record
Registry title: Radiotherapy of Head and Neck Cancer With SIB
Key facts
- Where
- Würzburg, GermanySee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a confirmed cancer of the head and neck who are having radiotherapy, with or without chemotherapy, at the University Hospital Würzburg.
- Age
- 18 years and older
- Sex
- All sexes can join
- Disease stage
- Cancer of the head and neck confirmed under the microscope, treated with definitive or adjuvant radio(chemo)therapy
Main reasons for not taking part
- No informed consent
- A mental or physical disorder that makes it impossible to understand or fill in the questionnaire
- The investigator judges that the person should not take part, or is unlikely to follow the study procedures
Read by machine on 9 November 2026.
Where in Germany
- University Clinic of WuerzburgWürzburg, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Wuerzburg University Hospital
- Trial code
- NCT06831903
- Record updated
- 18 February 2025
- Original description
Title: Simultaneous Integrated Boost in Primary and Adjuvant Therapy of Head and Neck Tumors: Quality Control Registry Prospective Longitudinal Observational StudyRead full original descriptionShow less
Simultaneous Integrated Boost in the Primary and Adjuvant Therapy of Head and Neck Cancer: Quality Control Registry Prospective Longitudinal Obervation Trial
Title: Simultaneous Integrated Boost in Primary and Adjuvant Therapy of Head and Neck Tumors: Quality Control Registry Prospective Longitudinal Observational Study
Short Title: Radiotherapy for Head and Neck Tumors with SIB
Objective: To evaluate the efficacy and safety of definitive and adjuvant radio(chemo)therapy with simultaneous integrated boost (SIB) in patients with head and neck cancers. The study aims to assess local and regional control, overall survival, metastasis-free survival, therapy-related toxicities, and quality of life.
Study Design: A prospective, longitudinal, non-interventional registry study documenting real-world outcomes and quality measures of therapy applied according to existing clinical guidelines.
Inclusion: Patients aged 18 and older with histologically confirmed malignant head and neck tumors, undergoing definitive or adjuvant radio(chemo)therapy at the University Hospital Würzburg.
Exclusion: mental or physical disorders leading to inability to understand and/or fill the quationary; missing informed consent; judgment by the investigator that the participant should not participate in the study if the participant is unlikely to comply with study procedures.